1. Home
  2. MGX vs NMS Comparison

MGX vs NMS Comparison

Compare MGX & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGX
  • NMS
  • Stock Information
  • Founded
  • MGX 2018
  • NMS 1993
  • Country
  • MGX United States
  • NMS United States
  • Employees
  • MGX N/A
  • NMS N/A
  • Industry
  • MGX
  • NMS Finance Companies
  • Sector
  • MGX
  • NMS Finance
  • Exchange
  • MGX NYSE
  • NMS Nasdaq
  • Market Cap
  • MGX 87.0M
  • NMS 71.8M
  • IPO Year
  • MGX 2024
  • NMS N/A
  • Fundamental
  • Price
  • MGX $2.36
  • NMS $12.44
  • Analyst Decision
  • MGX Strong Buy
  • NMS
  • Analyst Count
  • MGX 7
  • NMS 0
  • Target Price
  • MGX $16.67
  • NMS N/A
  • AVG Volume (30 Days)
  • MGX 654.7K
  • NMS 12.0K
  • Earning Date
  • MGX 03-04-2025
  • NMS 01-01-0001
  • Dividend Yield
  • MGX N/A
  • NMS 4.11%
  • EPS Growth
  • MGX N/A
  • NMS N/A
  • EPS
  • MGX N/A
  • NMS N/A
  • Revenue
  • MGX $55,080,000.00
  • NMS N/A
  • Revenue This Year
  • MGX $16.91
  • NMS N/A
  • Revenue Next Year
  • MGX N/A
  • NMS N/A
  • P/E Ratio
  • MGX N/A
  • NMS N/A
  • Revenue Growth
  • MGX 45.13
  • NMS N/A
  • 52 Week Low
  • MGX $1.61
  • NMS $9.21
  • 52 Week High
  • MGX $12.50
  • NMS $12.18
  • Technical
  • Relative Strength Index (RSI)
  • MGX 42.18
  • NMS 51.03
  • Support Level
  • MGX $2.34
  • NMS $12.36
  • Resistance Level
  • MGX $2.82
  • NMS $12.60
  • Average True Range (ATR)
  • MGX 0.21
  • NMS 0.07
  • MACD
  • MGX 0.00
  • NMS 0.01
  • Stochastic Oscillator
  • MGX 18.03
  • NMS 38.46

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).

About NMS Nuveen Minnesota Quality Municipal Income Fund

Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.

Share on Social Networks: